Randomized controlled trial to test efficacy of high-dose methotrexate consolidation therapy for BCR-ABL-negative acute lymphoblastic leukemia in adults.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Methotrexate (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 28 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 14 Nov 2008 Biomarkers information updated
- 13 Nov 2008 Checked against ClinicalTrials.gov record.